Intelliscend was founded in 2014, with an aim to provide one stop solution for all Selection, Development, Bioequivalence, Technology Transfer, Manufacturing, and Regulatory Approval needs. We are a team of skilled professionals with decades of experience in successfully enabling global Pharma companies with viable product pipelines along with an extensive experience across global generic Pharma companies. We have an expertise across all key domains in the Pharma value chain - Product Development, Regulatory, Clinical and Supply Chain, among others; and have enabled over 25 blockbuster molecules across regulated markets of the world.
There is no investment information
No recent news or press coverage available for Intelliscend NDDR.